Columnist Allyx Formalejo explains what people miss when they praise someone for simply living with a disability.

A 70-year-old man undergoing a leg amputation was diagnosed with a rare combination of acquired hemophilia A and Factor XII ...

Half of the children in Chile with severe hemophilia A and B exhibit joint damage despite receiving preventive treatment, a ...

Extended half-life therapies Eloctate and Alprolix safely and effectively controlled bleeds in hemophilia patients' surgeries ...

More often, Caeleb’s pain hums like a low-level alarm. He’s a living testament to resilience, with a will to keep moving that surpasses his hurt. This is the rhythm of his life, and he has learned to ...

Recognizing the link between bleeding disorders and Ehlers-Danlos syndrome is key to improving care, says columnist.

Unless you walk behind me and see the scar running down my spine, you wouldn’t know I have physical limitations. Admitting them often makes me feel less than. But it’s also a testament to my ...

What is giroctocogene fitelparvovec for hemophilia? Giroctocogene fitelparvovec, formerly known as SB-525 or PF-07055480, is a gene therapy being developed to reduce the risk of bleeding episodes in ...

What is Hemgenix for hemophilia? Hemgenix (etranacogene dezaparvovec-drlb) is a gene therapy approved to reduce the risk of bleeds in certain adults with hemophilia B. It is administered as a one-time ...

What is Mim8 for hemophilia? Mim8 (denecimig) is an antibody therapy being tested to prevent or reduce the frequency of bleeding episodes in people with hemophilia A, with or without neutralizing ...